TP53 and lung cancer: Ly6K mRNA expression was significantly higher in TP53 mutated lung cancer (n=18) than TP53 wildtye cancer (n=23), grade 3 adenocarcinoma (n=14) than grade 2 adenocarcinoma (n=18) in Ding [137] study.